About the role: The goal of the CRUK National Biomarker Centre (NBC), is to develop, validate, and implement biomarkers that facilitate the optimisation of cancer patient treatment. In this regard,
Read more
On Tuesday 22nd July, our Hidden Disabilities Sunflower initiative was launched part of our Equality, Diversity and Inclusion Strategy. Not all disabilities are visible, conditions such as autism, chronic pain,
Read more
Cancer Research UK National Biomarker Centre and Manchester Institute, alongside clinical colleagues at the Christie Hospital Foundation Trust, are major players within a newly formed consortium funded by substantial award to discover and develop biomarkers to understand and predict immunotherapy responses and side effects in cancer.
Read more
Dr Clipson and Dr Conway have received a Cancer Research UK Biomarker Project Award to optimise and validate a Tissue-of-origin (TOO) blood test ready for biomarker qualification and clinical implementation in patients with Cancers of Unknown Primary (CUP).
Read more